Media

BIO Investor Forum to be held October 7-8, 2014 in San Francisco, California
Survey responses will help inform Prescription Drug User Fee Act VI negotiations

Press Releases

Mar 25 2003
WASHINGTON, D.C. (March 25, 2003) – Next month’s BIO-Windhover 2003 conference in Washington, D.C. will highlight the key issues biotech companies face in...
Mar 24 2003
WASHINGTON, D.C. (March 24, 2003)- Venture capitalists nationwide will explore biotechnology investment opportunities in the Midwest at the BIO Mid-America...
Mar 20 2003
WASHINGTON, D.C. (March 20, 2003)— The Biotechnology Industry Organization (BIO) today announced that Stelios Papadopoulos, a leading expert in biotechnology...
Mar 12 2003
WASHINGTON, D.C. (March 12, 2003) – The Biotechnology Industry Organization (BIO) and the California Healthcare Institute (CHI) will host a breakfast,...
Mar 11 2003
WASHINGTON, D.C. (March 11, 2003)— The Biotechnology Industry Organization (BIO) today announced the list of start-up companies searching for private...
Mar 6 2003
WASHINGTON, D.C. (March 6, 2003)—The Biotechnology Industry Organization (BIO) in collaboration with eight Midwestern states and the Midwestern Health...
Feb 28 2003
Washington, D.C. (February 27, 2003) - Michael Werner, vice president for bioethics at the Biotechnology Industry Organization (BIO), today issued the...
Feb 27 2003
New York (February 27, 2003) – The Biotechnology Industry Organization (BIO) and Long Island Life Sciences Initiative (LILSI) announced today the...
Feb 21 2003
WASHINGTON, D.C. (February 21, 2003) - Three groups of industry experts will hold press briefings during the Biotechnology Industry Organization’s (BIO) CEO...


Biotechnology News

September 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) announces that management will present at the Morgan Stanley Global Healthcare Conference on Wednesday...

September 2, 2014

AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced that Richard Baron, Senior Vice President...

September 2, 2014

CINCINNATI--(BUSINESS WIRE)--Aerpio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases, today...

September 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today the appointment of Thomas Graney as chief financial officer (CFO) and...

September 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with...